Evidence map›Paper›PMID 33903100›Full record

ArticleAntimicrobial agents and chemotherapy2021

The Quorum-Sensing Inhibitor Furanone C-30 Rapidly Loses Its Tobramycin-Potentiating Activity against Pseudomonas aeruginosa Biofilms during Experimental Evolution.

Mona Bové, Xuerui Bao, Andrea Sass, Aurélie Crabbé, Tom Coenye

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Research Progress on the Quorum Sensing System ofPathogens (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Evolutionary adaptations ofMicrobiology spectrum · 2026
    Article
  7. Broadly Defined Antibiotic Adjuvants forThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Adaptation ofMicrobiology (Reading, England) · 2023
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mona BovéLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Xuerui BaoLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Andrea SassLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Aurélie CrabbéLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Tom CoenyeLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Ghent University · BE

Funding

Wellcome Trust
6 · The paper itself

Abstract

The use of quorum-sensing inhibitors (QSI) has been proposed as an alternative strategy to combat antibiotic resistance. QSI reduce the virulence of a pathogen without killing it and it is claimed that resistance to such compounds is less likely to develop, although there is a lack of experimental data supporting this hypothesis. Additionally, such studies are often carried out in conditions that do not mimic the

Indexed as

Pseudomonas aeruginosaTobramycinAnti-Bacterial AgentsBiofilmsFuransQuorum SensingAnti-Bacterial Agentsfuranone C-30FuransTobramycinbiofilmscystic fibrosisPseudomonas aeruginosaquorum sensing

Identifiers

PMID33903100
PMCPMC8373219
OpenAlexW3157999618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.